CVS Health Corporation $CVS Stock: Pictet Asset Management Holding SA Boosts Holdings

Pictet Asset Management Holding SA boosted its holdings in shares of CVS Health Corporation (NYSE:CVS) by 31.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,072,981 shares of the pharmacy operator’s stock after acquiring an additional 255,680 shares during the quarter. Pictet Asset Management Holding SA’s holdings in CVS Health were worth $91,951,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. BlackRock Inc. acquired a new position in shares of CVS Health during the second quarter worth $12,747,462,000. State Street Corp increased its holdings in CVS Health by 26.3% in the second quarter. State Street Corp now owns 74,927,064 shares of the pharmacy operator’s stock valued at $7,751,205,000 after purchasing an additional 15,604,883 shares during the period. Wellington Management Group LLP increased its holdings in CVS Health by 49.8% in the second quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock valued at $3,496,725,000 after purchasing an additional 11,233,381 shares during the period. Bank of America Corp DE increased its holdings in CVS Health by 148.0% in the second quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock valued at $2,398,868,000 after purchasing an additional 13,836,701 shares during the period. Finally, Pzena Investment Management LLC bought a new position in CVS Health during the 2nd quarter worth $1,217,558,000. Institutional investors own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have commented on CVS. Weiss Ratings downgraded CVS Health from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, October 9th. Argus increased their price target on CVS Health from $104.00 to $114.00 and gave the company a “buy” rating in a research note on Wednesday, August 19th. Truist Financial raised their price objective on CVS Health from $108.00 to $118.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $103.00 price objective on shares of CVS Health in a research note on Wednesday, November 4th. Finally, Raymond James Financial set a $103.00 target price on CVS Health in a report on Friday. Twenty-two analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $108.25.

Insider Transactions at CVS Health

In other CVS Health news, EVP Prem Shah purchased 23,855 shares of the company’s stock in a transaction on Friday, November 6th. The shares were purchased at an average cost of $83.89 per share, with a total value of $2,001,195.95. Following the completion of the purchase, the executive vice president owned 88,516 shares in the company, valued at $7,425,607.24. This represents a 36.89% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.85% of the company’s stock.

Key Stories Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: An executive bought about $2 million of CVS stock, a notable insider purchase that may signal confidence in the company’s outlook. Insider Buying: CVS Health EVP Buys $2,001,195.95 in Stock
• Positive Sentiment: CVS’s latest quarter beat analyst estimates for earnings and revenue. Management cited pharmacy strength, progress in Medicare margin recovery, improvement in its medical benefit ratio and solid cash generation—supportive signs for its operating outlook. The top 5 analyst questions from CVS Health’s Q3 2026 earnings call
• Neutral Sentiment: CVS’s planned separation into two entities is being framed as potentially beneficial to shareholders, but Mark Cuban argued it would do little for patients and called for legislation targeting healthcare monopolies. The breakup’s financial benefits remain a key investor question. Mark Cuban on the CVS breakup
• Neutral Sentiment: A reported $2.1 million settlement is small relative to CVS’s scale, so its direct financial impact appears limited. CVS settlement will see $2.1 million paid out
• Negative Sentiment: CVS is challenging Tennessee’s law barring pharmacies from owning pharmacy benefit managers. The dispute adds regulatory uncertainty around its integrated business model, even as the company says pharmacy services will continue uninterrupted. CVS Health challenges Tennessee PBM ownership ban in federal court

CVS Health Price Performance

CVS stock opened at $85.16 on Tuesday. The company has a quick ratio of 0.66, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The firm has a market cap of $108.92 billion, a price-to-earnings ratio of 9.91, a PEG ratio of 0.73 and a beta of 0.58. The company’s fifty day simple moving average is $90.21 and its 200 day simple moving average is $88.91. CVS Health Corporation has a 12-month low of $69.51 and a 12-month high of $110.68.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share for the quarter, topping the consensus estimate of $1.65 by $0.44. The firm had revenue of $108.40 billion during the quarter, compared to analyst estimates of $104.72 billion. CVS Health had a return on equity of 13.65% and a net margin of 2.62%. The business’s quarterly revenue was up 5.4% on a year-over-year basis. During the same period last year, the company posted $1.60 EPS. On average, analysts expect that CVS Health Corporation will post 8.25 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd were issued a $0.6650 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.1%. The ex-dividend date was Thursday, October 22nd. CVS Health’s payout ratio is presently 30.97%.

About CVS Health

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division.

The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Founded in 1963 as Consumer Value Stores in Lowell, Massachusetts, the company expanded from a retail pharmacy business into a broad health care organization and adopted the CVS Health name in 2014.